Navigation Links
New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma
Date:5/16/2008

the FDA of VELCADE and rituximab versus rituximab alone in patients with relapsed follicular lymphoma. Final data are expected in 2010. These trials support the Company's comprehensive development program in NHL.

About Multiple Myeloma

Multiple myeloma is the second most common hematologic malignancy and although the disease is predominantly a cancer of the elderly (the median age of onset is 70 years), recent statistics indicate both increasing incidence and younger age of onset. In the U.S., more than 50,000 individuals have MM and 20,000 new cases are diagnosed each year. Worldwide there are approximately 74,000 new cases and over 45,000 deaths annually.

About Non-Hodgkin's Lymphoma (NHL) and Mantle Cell Lymphoma (MCL)

NHL is the most common hematological cancer, the fifth leading cause of cancer death and the second fastest growing form of cancer in the U.S. The prevalence of NHL in the U.S. is approximately 400,000 patients, including approximately 200,000 patients with diffuse large B-cell lymphoma, 100,000 patients with follicular and marginal zone lymphoma and 10,000 with MCL. There are approximately 54,000 new cases of NHL diagnosed in the U.S. per year, and 19,000 deaths are attributed to the disease annually.

MCL is an aggressive, rapidly progressive subtype of NHL, and is not curable with standard treatment. The median life expectancy for a patient with MCL following first relapse is one to two years.

About VELCADE

VELCADE is being co-developed by Millennium Pharmaceuticals, The Takeda Oncology Company, and Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Millennium is responsible for commercialization of VELCADE in the U.S. and Janssen-Cilag is responsible for commercialization in Europe and the rest of the world. Janssen Pharmaceutical K.K. is responsible for commercialization in Japan. For a limited period of time, Millennium and Ortho Biotech Inc. are co-promoting VELCADE in the U.S. VE
'/>"/>

SOURCE Millennium Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents
2. Lupus Under the Spotlight: U.S. Congress Shows Support for Womens Health Issues
3. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
4. ISTA Pharmaceuticals Announces New Phase III Clinical Findings to Support Bepreve NDA Filing
5. More Clinical Data Required to Support European Approval of CAP Indication for TYGACIL
6. Data Presented at AAN Support Potential for Adjunctive use of Intravenous Lacosamide as Short-Term Replacement for Oral Treatment in Partial Epilepsy
7. DSMB Supports Continuation of Anthera Phase II Impacts Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
8. Fifth DSMB Meeting Supports Neurobiological Technologies Continuation of Phase 3 Stroke Trials With Viprinex(TM) (ancrod)
9. Karmanos Cancer Institute Research Supports Role of Inflammation to Determine Lung Cancer Risk, Particularly in African-American Women
10. Pharmacyclics Announces Preclinical Results Supporting Development of Its Novel Btk Inhibitor in Immune Mediated Diseases
11. Supportive Oncology Services Accrues One Million Cancer Patient Self-Reported Assessments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... - New Solution That Makes ... JIN Co., Ltd. will launch JINS MEME "ACADEMIC PACK" ... yen or $5,000 (without tax /including two pairs of JINS ... a dedicated solution of "JINS MEME" to academic researchers, and ... generated by electrooculography and six-axis sensors without API. (*Physiological data ...
(Date:11/26/2014)... 2014  Thoratec Corporation (NASDAQ: THOR ), ... to save, support and restore failing hearts, said today ... On Tuesday, December 2, the company will ... Healthcare Conference.  D. Keith Grossman , President and ... company beginning at 11:30 a.m., Eastern Standard Time (8:30 ...
(Date:11/26/2014)...   Royal Philips (NYSE: ... of its portfolio of diagnostic X-ray solutions ... , ProGrade and PrimaryDiagnost[ii]. With new releases of ... U.S., and availability of all these solutions in ... innovative solutions designed to meet the needs and ...
Breaking Medicine Technology:JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 2JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 3Thoratec Announces Presentations At Investor Conferences For December 2014 2Philips expands global reach of diagnostic X-Ray solutions 2Philips expands global reach of diagnostic X-Ray solutions 3
... -- Cylene Pharmaceuticals, Inc. has been selected to ... at the 52nd Annual Meeting of the American Society of ... FL, the company announced today.  Kenna Anderes, VP Cancer Biology ... kinase that is essential for the progression of multiple myeloma ...
... 2010 Keryx Biopharmaceuticals, Inc. (Nasdaq: ... first time at the 52nd Annual Meeting of ... activity, safety and tolerability of perifosine in patients ... lymphoma (HL).  KRX-0401 (perifosine) is the Company,s novel, ...
Cached Medicine Technology:Cylene Selected to Present CK2 Inhibitor Multiple Myeloma Data at American Society of Hematology Meeting 2Cylene Selected to Present CK2 Inhibitor Multiple Myeloma Data at American Society of Hematology Meeting 3Phase 2 Data Presented at the 52nd Annual Meeting of the American Society of Hematology Demonstrates Promising Efficacy of KRX-0401 (Perifosine) in the Treatment of Advanced Leukemia, Lymphoma and Multiple Myeloma 2Phase 2 Data Presented at the 52nd Annual Meeting of the American Society of Hematology Demonstrates Promising Efficacy of KRX-0401 (Perifosine) in the Treatment of Advanced Leukemia, Lymphoma and Multiple Myeloma 3Phase 2 Data Presented at the 52nd Annual Meeting of the American Society of Hematology Demonstrates Promising Efficacy of KRX-0401 (Perifosine) in the Treatment of Advanced Leukemia, Lymphoma and Multiple Myeloma 4Phase 2 Data Presented at the 52nd Annual Meeting of the American Society of Hematology Demonstrates Promising Efficacy of KRX-0401 (Perifosine) in the Treatment of Advanced Leukemia, Lymphoma and Multiple Myeloma 5
(Date:11/27/2014)... Thanksgiving meals can pose a challenge for people who ... Many traditional Thanksgiving dishes -- such as turkey, ... but "when it comes to pies, stuffing, gravy, etc., ... Safta, director of the Gluten and Allergic Digestive Disorders ... Carolina, said in a center news release. "For ...
(Date:11/27/2014)... 2014 Tylenol lawsuits ( http://www.tylenollawsuitcenter.com/ ) ... by the medication are continuing to move forward in ... ahead to a status conference in December, Bernstein Liebhard ... issued earlier this year, a conference in the Tylenol ... a.m. Items likely to be discussed at the meeting ...
(Date:11/27/2014)... Aliso Viejo, California (PRWEB) November 27, 2014 ... have announced a new plugin entitled ProPip, taking FCPX to ... picture in picture effect with a few clicks of a ... is a time saver that our users will appreciate.” , ... with full customization leaving the possibilities truly endless. ProPip is ...
(Date:11/27/2014)... 27, 2014 Allowing children to help with ... school, helps give children responsibility, ownership, boosts self-esteem, and above ... , Now, the real question is, how do you encourage ... According to a study published by Child Development Journal, there ... dramatic effect on a child’s willingness to lend a hand. ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 The Emerald ... An Up-Close Look At This Year’s Entries | SKUNK ... All-Inclusive Stay For Two At Their Resort, Pure Garden, ... events or L.A.-based Hempcon, The Emerald Cup is presented ... fair draws much of California’s original cannabis industry." – ...
Breaking Medicine News(10 mins):Health News:Expert Shares Gluten-Free Thanksgiving Tips 2Health News:Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports 2Health News:Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports 3Health News:Pixel Film Studios released ProPip plugin Exclusively for Final Cut Pro X 2Health News:Pixel Film Studios released ProPip plugin Exclusively for Final Cut Pro X 3Health News:The Emerald Cup 2014 Competition Partners | CannCast – Bringing You An Up-Close Look At This Year’s Entries and SKUNK Magazine Proudly Sponsoring This Year's Grand Prize 2Health News:The Emerald Cup 2014 Competition Partners | CannCast – Bringing You An Up-Close Look At This Year’s Entries and SKUNK Magazine Proudly Sponsoring This Year's Grand Prize 3Health News:The Emerald Cup 2014 Competition Partners | CannCast – Bringing You An Up-Close Look At This Year’s Entries and SKUNK Magazine Proudly Sponsoring This Year's Grand Prize 4
... Site Initiatives, Connecting ,Women Directly with Top Board-Certified Urologist for ... ... N.J.(PRWEB) April 15, 2009-- Physician-recommended Cystex®, the first and only ... progression of a urinary tract infection (UTI), announces the launch ...
... MIAMI, April 16 Get Ready ... Making Waves in Miami will be held April 30-May 2, 2009 ... on the New Dentist for a weekend of networking, continuing education ... earn up to 11 credit hours and have the opportunity to ...
... with experts on clinical development: Copenhagen and Munich ... International, a leading Clinical Research Organization, will host ... challenges posed by current market conditions, improve planning ... efficiency working with different vendors throughout the development ...
... Permanente leads health plans in member satisfaction in ... Kaiser Permanente announced today that its members in ... highest in customer satisfaction in the J.D. Power ... The regions are Colorado, Virginia-Maryland, California and ...
... factor is one women can do little about, experts say ... have known that breast density is almost as important as ... now they,re discovering how the density of a woman,s breast ... treatment and whether her cancer will recur. , The denser ...
... Pulse CO-Oximetry(TM) Could Generate Nearly $500,000 in Net ... April 16, Masimo (Nasdaq: MASI ), ... and Low-Perfusion pulse oximetry, announced today that Capgemini, ... services, has released a study showing that a ...
Cached Medicine News:Health News:Know Your Bladder Better 2Health News:Know Your Bladder Better 3Health News:Video: ADA 23rd New Dentist Conference: Making Waves in Miami 2Health News:Video: ADA 23rd New Dentist Conference: Making Waves in Miami 3Health News:PRA Hosts Biotech 2009 - Challenges and Opportunities in R&D 2Health News:Kaiser Permanente Receives Top Marks in 2009 J.D. Power and Associates Study 2Health News:Kaiser Permanente Receives Top Marks in 2009 J.D. Power and Associates Study 3Health News:Kaiser Permanente Receives Top Marks in 2009 J.D. Power and Associates Study 4Health News:Dense Breasts Complicate Testing and Treatment 2Health News:Dense Breasts Complicate Testing and Treatment 3Health News:Capgemini Releases New Study on Financial Impact of Masimo Noninvasive and Continuous Hemoglobin (SpHb(TM)) 2Health News:Capgemini Releases New Study on Financial Impact of Masimo Noninvasive and Continuous Hemoglobin (SpHb(TM)) 3Health News:Capgemini Releases New Study on Financial Impact of Masimo Noninvasive and Continuous Hemoglobin (SpHb(TM)) 4
The maternity apron is a very critical protection device for the patient and the fetus....
... our coat apron, weight is distributed ... of comfortable wear without fatigue. Made ... our front closing special procedure apron ... closures that make it a cinch ...
... X-ray Aprons are the result of a ... leaded x-ray aprons. Constructed with a wear ... back, the Lead Free aprons exhibit the ... apron. Each apron weighs approximately 50% less ...
... The Triage BNP Test is the ... test measuring B-type natriuretic peptide (BNP) ... ventricles in response to ventricular volume ... marker of ventricular systolic and diastolic ...
Medicine Products: